Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.34 |
| ▸ | PTPRC | P08575 | 1/20 | 0.34 |
| ▸ | PTPRF | P10586 | 1/20 | 0.34 |
| ▸ | CDC25B | P30305 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28887375 | 1.00 | PTPN1 (0.34) | PTPN1PTPRCPTPRFCDC25BMEN1 | |
| SCHEMBL29860849 | 0.84 | PTPN1 (0.35) | PTPN1PTPRCPTPRFCDC25BMEN1 | |
| SCHEMBL29555282 | 0.82 | PTPN1 (0.47) | PTPN1PTPRCPTPRFCDC25BALDH1A1 | |
| SCHEMBL19547127 | 0.78 | PTPN1 (0.37) | PTPN1PTPRCPTPRFCDC25BMEN1 | |
| SCHEMBL994818 | 0.78 | PTPN1 (0.37) | PTPN1PTPRCPTPRFCDC25BMEN1 | |
| Hydrochloric Acid SCHEMBL4450657 | 0.77 | PTPN1 (0.36) | PTPN1PTPRCPTPRFCDC25BMEN1 | |
| Hydrochloric Acid SCHEMBL994817 | 0.77 | PTPN1 (0.36) | PTPN1PTPRCPTPRFCDC25BMEN1 | |
| SCHEMBL4744729 | 0.76 | CYP3A4 (0.40) | PTPN1PTPRCPTPRFCDC25BALDH1A1 | |
| SCHEMBL28981793 | 0.73 | PTGS2 (0.32) | — | |
| Biphenyl SCHEMBL28193720 | 0.73 | ALDH1A1 (0.43) | MEN1KMT2AALDH1A1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018333-A1 | Producing Recycled Carbon Black from Waste Tires | EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) | 2024-01-18 | — | — | US | claimed |
| EP-3126407-B1 | SPACER GROUPS FOR FUNCTIONALIZED RESINS IN TIRES | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2022-08-03 | — | — | EP | claimed |
| EP-3077433-B1 | FUNCTIONALIZED RESINS FOR HIGH PERFORMANCE TIRES | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2022-04-20 | — | — | EP | claimed |
| US-10384987-B2 | 1,3-butadiene synthesis | ARLANXEO DEUTSCHLAND GMBH (DE) | 2019-08-20 | — | — | US | claimed |
| EP-3233768-B1 | 1,3-BUTADIENE SYNTHESIS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2019-02-20 | — | — | EP | claimed |
| EP-3099654-B1 | SYNTHETIC METHOD | UNIV COURT UNIV ST ANDREWS (GB) | 2018-05-09 | — | — | EP | claimed |
| EP-2771339-B1 | IMPROVED PROCESS FOR PREPARING AN INTERMEDIATE OF THE MACROCYCLIC PROTEASE INHIBITOR TMC 435 | JANSSEN PHARMACEUTICALS INC (US) | 2018-04-18 | — | — | EP | claimed |
| US-9908826-B2 | Synthetic method | UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2018-03-06 | — | — | US | claimed |
| US-9840569-B2 | Spacer groups for functionalized resins in tires | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-12-12 | — | — | US | claimed |
| US-20170327436-A1 | 1,3-BUTADIENE SYNTHESIS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2017-11-16 | — | — | US | claimed |
| US-20130030126-A1 | Olefin Functionalization By Metathesis Reaction | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-01-31 | — | — | US | claimed |
| US-8283419-B2 | Olefin functionalization by metathesis reaction | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-10-09 | — | — | US | claimed |
| WO-2012134722-A2 | DIBLOCK COPOLYMERS PREPARED BY CROSS METATHESIS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-10-04 | — | — | WO | claimed |
| US-20120245294-A1 | Olefin Triblock Polymers via Ring-Opening Metathesis Polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2012-09-27 | — | — | US | claimed |
| US-20120245290-A1 | Diblock Copolymers Prepared by Cross Metathesis | EXXONMOBIL CHEMICAL PATENTS INC. | 2012-09-27 | — | — | US | claimed |
| JP-2011525213-A | — | — | 2011-09-15 | — | — | JP | claimed |
| EP-2318446-A2 | OLEFIN FUNCTIONALIZATION BY METATHESIS REACTION | ExxonMobil Chemical Patents Inc. (US) | 2011-05-11 | — | — | EP | claimed |
| WO-2009155517-A2 | OLEFIN FUNCTIONALIZATION BY METATHESIS REACTION | EXXONMOBIL CHEMICAL PATENT INC. (US) | 2009-12-23 | — | — | WO | claimed |
| WO-2006110471-A2 | MICROPOROUS POLYDICYCLOPENDIENE-BASED AEROGELS | ASPEN AEROGELS, INC. (US) | 2006-10-19 | — | — | WO | claimed |
| US-20060229374-A1 | MICROPOROUS POLYDICYCLOPENDIENE-BASED AEROGELS | MIDCAP FUNDING IV TRUST | 2006-10-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10384987-B2 | 1,3-butadiene synthesis | SQLE, FDFT1, ENO1 | PTPN1 4601/4885PTPRC 4573/4885PTPRF 4451/4885 |
| US-20170327436-A1 | 1,3-BUTADIENE SYNTHESIS | SQLE, FDFT1, ENO1 | PTPN1 4601/4885PTPRC 4573/4885PTPRF 4451/4885 |
| US-20130030126-A1 | Olefin Functionalization By Metathesis Reaction | MAX, AP1M1, AP3M1 | PTPN1 4144/4885PTPRC 3276/4885PTPRF 2524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.